INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion
Go back to INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion| (NASDAQ: INMB) | Delayed: 1.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.84 | 52 Week High | $ | |||
| Open | $1.84 | 52 Week Low | $ | |||
| Day High | $1.84 | P/E | N/A | |||
| Day Low | $1.84 | EPS | $ | |||
| Volume | 809 | |||||
| (NASDAQ: INMB) | Delayed: 1.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.84 | 52 Week High | $ | |||
| Open | $1.84 | 52 Week Low | $ | |||
| Day High | $1.84 | P/E | N/A | |||
| Day Low | $1.84 | EPS | $ | |||
| Volume | 809 | |||||

